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IN a previous experiment (Biancifiori, Bonser and Caschera, 1959) it was shown
that a limited dose of 20-methylcholanthrene (MC) failed to induce mammary
tumours in virgin or lobectomised BALB/c mice but that if the mice were made
pseudopregnant 44 per cent developed mammary carcinomas. In a further
experiment (Biancifiori and Cashera, 1962) it was shown that a larger dose ofMC
still caused only occasional tumours in lobectomised or virgin mice, but that 33
per cent of pseudopregnant mice developed tumours. It was also shown that
pseudopregnancy enhanced the tumour yield over that in virgins when the
carcinogen was 9,10-dimethyl-1,2-benzanthracene (DMBA), 1,2: 5,6-dibenzan-
thracene (DBA) or 3,4-benzopyrene (BP). It was concluded that pseudo-
pregnancy supplied two factors contributory to carcinogenesis by these chemicals,
oestrogen and progesterone, but there was no information as to whether both
hormones were necessary. The present experiments were undertaken with a dual
purpose: firstly, to find out whether pseudopregnancy could be replaced by
oestrogen alone if given continuously and secondly, to investigate whether the
action of oestrogen would be similar when the carcinogen was varied. The idea
of an oestrogen or progesterone pathway through which chemical carcinogens
might exert their action had been postulated by Jull (1958).
MATERIAL AND METHODS
Nine hundred and eight virgin female BALB/c/Cb/Se mice were used. Seven
hundred and eighty survived for sufficient time to be reported, 403 intact and 377
ovariectomised (Table I).
Ovariectomy was performed through double flank incisions, under ether
anaesthesia, at about 6 weeks ofage. Thereafter both normal and castrated mice
were maintained, 5 to a cage, on the standard pelleted diet of the laboratory.
Oestrone (The British Drug Houses, Ltd.) was dissolved in the drinking water
at the required level and was presented to the mice ad libitum 1 weekbefore chemi-
cal treatment was started. The oestrone was changed every second day, and was
administered until the death of the animals.
DMBA, DBA, MC and BP (L. Light and Co. Ltd.) were dissolved in almond oil
at a concentration of 0 5 per cent; 0.1 ml. (0 5 mg.) was administered by stomach
tube twice weekly to the mice when they reached 8 weeks ofage. This treatment
was continued for 15 weeks. As DMBA at this level was too toxic, experiments
IV D, IV E and IV F were started, in which the carcinogen was given for 8 weeks
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TABLE I.-Chemicals Administered to the Mice Used in These Experiments
Oestrone Number ofeffective mice*
Dose (,ug.
Experiment Chemical (mg.) per litre) Intact Ovariectomised
I G . . - . 500 . 24(25) 25(25)
I H . _ . - . 1000 . 24(24) 27(27)
I A . DBA . 15 . - . 20(22) 19(21)
I B . DBA . 15 10 . 14(15) 19(21)
I C . DBA . 15 . 50 . 25(25) 10(16)
I D . DBA . 15 . 100 . 21(21) 20(21)
I E . DBA . 15 . 500 . 19(19) 19(21)
I F . DBA . 15 . 1000 . 20(25) 17(17)
II A . MC . 15 . . 25(25) 25(25)
II B . MC . 15 . 500 . 25(25) 24(24)
II C . MC . 15 . 1000 . 21(23) 24(25)
III A . BP . 15 . . 25(25) 25(25)
III B . BP . 15 . 500 . 25(25) 23(25)
III C . BP . 15 . 1000 . 26(26) 20(21)
IV A . DMBA . 15 . - . 24(25) 18(25)
IV B . DMBA . 15 . 500 . 17(25) 19(25)
IV C . DMBA . 15 . 1000 17(25) 15(25)
IV D . DMBA . 8 . - .13(20) 9(20)
IV E . DMBA . 8 . 500 . 11(20) 7(20)
IV F . DMBA . 8 . 1000 . 7(20) 12(20)
403(459) 377(449)
* Mice which survived to the date of appearance of the first tumour caused by each chemical or
until 51 weeks of age when no chemical was given. Figures in parenthesis represent the number of
mice at the start.
The minimum time the mice had to survive to be included in the results ofthe
experiments was determined by the interval between the first administration ofthe
carcinogen andthe discovery ofthe first tumour ofany organ withthat carcinogen.
This period was: 4 and 7 weeks with 15 and 8mg. DMBA respectively; 16
weeks with DBA; 24 weeks with BP and 36 weeks with MC. In experiments
I G and I H, where no carcinogen was administered, the first effective mouse died
aged 52 weeks, i.e. 44 weeks after the time at which the carcinogens had been
administered to the other mice.
RESULTS
Mammary carcinomas
In Table II is stated the incidence of mammary carcinomas in the groups of
intact and ovariectomised mice treated as shown in Table I. Table III is a
summary of the chemical and the oestrogenic effects, the numbers of tumours
occurring with 500 and 1000 ,ug./l. ofoestrogen being considered together.
The general effect of a combination of oestrone and chemical was to increase
the number of tumours above that induced by chemical or hormone alone, both
in intact and ovariectomised mice (Table III). Usually thehigher dose of 1000 ,tg.
per litre in the drinking water was more effective than a lower dose of 500 ,ltg.
per litre (Table II). However, in the one experiment where lower doses of
oestrone were tried (Expt. I, B-D) a considerable effect was obtained in intact
mice at doses of 10, 50 and 100 ,ug. of oestrone per litre.
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TABLE II.-Mammary Carcinoma8 in Intact and Ovariectomnied BALB/c Mice
Treated with Chemicatg and Oe8trone
Intact Ovariectomised
, A \ ~AA
Dose of Mammary carcinomas Mammary carcinomas
oestrone A__
Chemi- (,ug. per Survival Per Mean Survival Per Mean
Exper. cal litre) (weeks) No. cent age (weeks) No. cent age
I A DBA None 16 44 1/20 5 26 22-44 0/19 0
B 10 27-52 3/14 21 48 23-52 0/19 0
C 50 27-52 10/25 40 39 27-54 1/10 10 38
D 100 24-48 8/21 38 38 23-47 1/20 5 28
E 500 25-38 3/19 16 35 23-41 1/19 5 25
F 1000 16-46 11/20 55 25 24-26 3/17 18 31
II A MC None 41-54 4/25 16 53 43-61 2/25 8 56
B 500 45-59 13/25 52 49 45-59 4/24 17 53
C 1000 36-44 16/21 76 40 36-44 7/24 28 41
III A BP None 28-65 2/25 8 57 24-64 0/25 0
B 500 26-60 4/25 16 39 24-58 0/23 0
C 1000 26-56 2/26 8 37 28-54 1/20 5 48
IV A DMBA None 4-14 0/24 0 7-15 2/18 11 10
B (15) 500 7-14 1/17 6 7 7-11 0/19 0
C 1000 8-15 2/17 12 9 8-15 2/15 13 10
IV D DMBA None 8-21 0/13 0 - 7-21 0/9 0
E (8) 500 9-23 4/11 36 13 7-24 0/7 0
F 1000 9-20 1/7 14 17 7-21 2/12 17 12
I G None 500 61-65 0/24 0 45-64 0/25 0
H 1000 51-63 0/24 0 - 44-63 0/27 0 -
Figures in parenthesis represent total oral dose (mg.) of DMBA.
TABLE III.-Summary ofEffect ofOestrone on Mammary Tumour Induction
Intact Ovariectomised
Presence or Mammary tumours Mammary tumours
absence of
A -A_,_-_
Exper. Chemical oestrone No. Per cent No. Per cent
I . DBA . None . 1/20 5 . 0/19 0
500 or 1000 g. . 14/39 36 . 4/36 11
II . MC . None . 4/25 16 . 2/25 8
500 or 1000 ,.g. . 29/46 63 . 11/48 23
III . BP . None . 2/25 8 . 0/25 0
500 or 1000 ,ug. . 6/51 12 . 1/43 2
IV . DMBA . None . 0/24 0 . 2/18 11
(15) 500 or 1000 ,ug. . 3/34 9 . 2/34 6
DMBA . None . 0/13 0 . 0/9 0
(8) 500 or 1000 tg. . 5/18 28 . 2/19 11
I . None . 500 or 1000 itg. . 0/48 0 . 0/52 0
Figures in parenthesis represent total oral dose of (mg.) DMBA.
It is now necessary to analyse the results obtained in individual groups of
mice.
Ovariectomi8ed mice (Table II).-The effect ofoestrone at both the doses given
(natural progesterone being absent) can be seen. Mammary carcinoma induction
by DBA and MC was appreciably increased, but that by BP was not increased.ACTION OF OESTRONE AND CARCINOGENS IN MICE
Any effect by DMBA was equivocal, owing to the short survival of the mice,
especially of those which had the high dose ofDMBA (Groups IV, A-C). But the
14 tumours which did occur appeared at mean ages ranging from 7-17 weeks,
which can be regarded as early. Oestrone alone failed to induce mammary
carcinomas in spite of long survival (Groups I, G and H).
Intact mice.-The effect of oestrone (progesterone being supplied by the
ovary) was rather greater than in ovariectomised mice. DBA and MC induced
the highest number oftumours (Table III), the effect ofBP was minimal and that
with DMBA equivocal, owing to the early death ofthe mice.
All the tumours in ovariectomised and intact mice were confirmed micro-
scopically as mammary adenocarcinomas, of the type associated with chemical
induction (Bonser, Dossett and Jull, 1962). One tumour was classified as a
carcinosarcoma and in 3, areas of squamous metaplasia were observed. In
addition there were 5 mammary sarcomas, which are not included in the analysis
of carcinomas. Three were in mice treated with DBA. Two of these mice had
received no oestrone; one was intact and was killed at 16 weeks, while the other
was an ovariectomised mouse and died at 29 weeks. The third DBA sarcoma
occurred in an ovariectomised mouse which had received a high level of oestrone
and was killed at 30 weeks. The other 2 sarcomas arose in mice treated with MC.
One was ovariectomised and received 1000 ,ug./l. oestrone until killed at 37 weeks;
the other was intact, receiving 500 jag./l. oestrone until killed at 51 weeks.
Gastric tumours
None occurred with DBA or MC but there were many following treatment
with BP and DMBA, whether oestrone was administered or not and whether the
mice were ovariectomised or intact (Table IV). The more effective carcinogen
was DMBA, the first tumour occurring at 4 weeks and all the tumours having
occurred by 22 weeks. With BP the range oftumour induction was 26-60 weeks.
The gastric tumours were all squamous carcinomas of the forestomach, with
varying degrees of infiltration of the sub-epithelial tissue and muscular wall.
One gastric carcinoma induced by BP and found at 29 weeks had invaded both
ovaries by spreading across the peritoneum.
Ovarian tumours
The highest incidence was obtained in mice treated with DBA and oestrone.
None occurred following treatment with DBA alone or oestrogen alone (Groups I,
A, G and H) nor with the lowest dose of oestrone (Group I, B). Eight tumours
occurred when the dose of oestrone was 50 or 100 ,ug. per litre (Groups I, C and
D) and 9 when the higher doses were given (Groups I, E and F), the numbers of
effective mice being 46 and 39 respectively (Table I). The latent period was
17-39 weeks. Twelve of the tumours were classified as of granulosa-cell origin,
4 as luteomas and 1 as mixed.
Three ovarian tumours occurred in group II A and 2 in group III A, where MC
or BP was administered without oestrogen. The mean latent period with MC
was 50 weeks and with BP 62 weeks. One tumour occurred at 51 weeks with
MC and 500 ,ug. oestrone (Group II, B), one at 48 weeks with BP and 1000 ,tg.
(Group III, C) and another at 20 weeks with DMBA and 1000 ,ug. oestrone (Group
IV, F). All these 8 tumours were ofgranulosa-cell type.
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Leukaemia
All instances except 3 were ofmyeloid type. The condition did not occur when
the carcinogen was DBA or MC or with oestrone alone. There were 9 myeloid
cases with BP. Four were in ovariectomised mice, one without oestrone, one at
500 ,ug. oestrone and 2 at 1000 ,ug. Five were in intact mice, 2 at 500 ,ug. and 3
at 1000 jig. of oestrone. The age range was 24-48 weeks. There were 13 in-
stances (10 of myeloid and 3 oflymphatic type) when DMBA was the carcinogen,
4 when the dose was high (Group IV, A-C) and 9 when it was low (Group IV,
D-F). Of the former, 2 instances occurred in intact mice without oestrone and 2
in ovariectomised mice with 1000 ,tg. oestrone. Of the latter, 5 occurred in mice
without oestrone, 2 in ovariectomised and 3 in intact; 4 occurred in mice with
500 ,tg. of oestrone, 2 in ovariectomised and 2 in intact. The age range was
16-24 weeks.
Lung tunours
Both adenomas and carcinomas of the lung were found frequently in mice
treated with DBA, MC and BP, and occasionally in the shorter lived mice treated
with DMBA. The incidence of these tumours is being analysed and will be
reported in conjunction with present studies on the influence of hormones on
pulmonary carcinogenesis.
DISCUSSION
Mamnary carcinomas.-Only occasional tumours were induced in ovariecto-
mised mice by any 1 ofthe 4 chemicals alone (4 out of 96) but even this number is
surprising in view of the absence of ovarian or administered hormones. As in a
previous experiment (Biancifiori and Caschera, 1962) the incidence was also low
in intact virgins (6 out of 107). The simultaneous administration of large doses
of oestrone in the drinking water caused an overall increase in the incidence of
mammary carcinomas, less evident in ovariectomised than in intact mice. The
order ofpotency of the chemicals in this respect was MC, DBA and BP, the latter
being only weakly effective. The action of DMBA was equivocal owing to short
survival, though the tumours which did occur appeared at a very early time.
Such a result fails to lend support to the idea that breast carcinogens act via a
specific hormonal pathway (Jull, 1958) for had such been the case it would have
been expected that the incidence of mammary tumours following DBA and BP
(which have oestrogenic properties) would have been considerably higher than
that following MC and DMBA (which have progestogenic properties). It would
seem more likely that MC and DBA are " strong " mammary carcinogens by
virtue of their chemical and physical properties which govern their concentration
and their reaction in the mammary tissue. It is possible, of course, that the dose
of chemical and oestrogen chosen was not optimum. When lower doses of
oestrone (10, 50 and 100 ,g. per litre in the drinking water, Groups I, B, C and D)
were combined with DBA as good a yield of mammary carcinomas was obtained
as when the higher doses (500 and 1000 ,tg.) were used. Therefore differentiation
in action of the carcinogens might have been demonstrated more readily had the
doses of oestrogen been lower.
A little light is thrown on the mechanism of action of pseudopregnancy,
which was shown to be a favourable factor in mammary carcinoma induction in
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BALB/c mice in previous experiments (Biancifiori et al., 1959; Biancifiori and
Cashchera, 1962). The overall incidence of mammary tumours was higher in
oestrone-treated intact than ovariectomised mice, which suggests that the pro-
gesterone supplied by the ovary aids tumour induction. How such a mechanism
acts has not been elucidated by these experiments.
Five mixed cell (round and spindle cell) sarcomas of the breast were observed.
Haemangiosarcomas were induced previously by Biancifiori and Caschera (1962)
by oral MC and BP and it was suggested that the carcinogen was concentrated in
the fat pad. It would seem that neither hormonal nor specific chemical factors
play a part in the induction of this type of tumour of the breast.
Gastric tumours.-These were keratinising squamous carcinomas of the
forestomach, of invasive type, occurring only when BP and DMBA were the
carcinogens. The hormonal status of the mouse did not appear to be a factor in
their induction (Table IV). This type of tumour was not observed in intact or
pseudopregnant mice in the previous experiment (Biancifiori and Caschera, 1962)
although the carcinogenic dosage was approximately similar. It is to be noted
that the gastric tumours induced by DMBA occurred very early, i.e. before 24
weeks following the start of treatment, and considerably earlier than those
induced by BP. The occurrence of gastric tumours was a factor in the short
survival of DMBA-treated mice.
Ovarian tumours.-These occurred outstandingly only when DBA was the
carcinogen and when oestrone was present (Groups I, C-F). They were largely
of granulosa-cell type. The occasional tumours after MC and BP occurred in
both the absence or presence of oestrogen and only one was induced by DMBA
(where survival was not adequate). In the previous experiment oral BP and DBA
did not induce ovarian tumours in pseudopregnant, lobectomised or virgin mice
with good survival but the potent carcinogens in this respect were MC and DMBA.
It thus seems that in the present experiments oestrone did enhance the yield of
ovarian tumours with DBA but not with MC.
Leukaemia.-No special study was made of this condition but it was noted to
occur with BP and DMBA, though not with DBA nor MC. Intact ovaries or
administered oestrone were necessary except in one instance. Recently Ribacchi
and Giraldo (1966) showed that the spontaneous incidence ofleukaemia in BALB/
c/An/Se mice, a substrain similar to BALB/c/Cb/Se but derived directly from
Andervont and also without the mammary tumour agent, was about 5 per cent in
female breeders at 98 weeks of age.
SUMMARY
(1) Groups of approximately 25 BALB/c mice, either intact or ovariectomised,
received 4 chemical carcinogens by mouth together with oestrone at 500 and
1000 ,tg. per litre in the drinking water. Control groups received carcinogen
alone or oestrone alone.
(2) Administration of oestrone increased the incidence of mammary carcino-
mas in both intact and ovariectomised mice when DBA or MC were the carcino-
gens; only a minimal effect was obtained with BP and the result with DMBA was
equivocal owing to short survival of the mice.
(3) No support was obtained in these experiments for the idea that chemical
carcinogens induce breast carcinoma through a specific hormonal pathway, but
the probability exists that the dose of oestrone chosen was too high. As theACTION OF OESTRONE AND CARCINOGENS IN MICE 459
incidence of tumours was higher in intact than in ovariectomised mice it was
concluded that the progesterone supplied by the ovary was a factor favourable to
carcinogenesis. This would explain why pseudopregnancy was advantageous in
previous experiments.
(4) Squamous carcinomas of the forestomach occurred when the carcinogen
was BP or DMBA, the latter appearing very early. Administration of oestrone
did not affect the incidence.
(5) DBA with oestrone induced ovarian tumours, mostly of granulosa-cell
type, even when the dose ofoestrone was reduced to 50 or 100jig. per litre (Groups
I, C and D). This is in contrast to the absence ofsuch tumours in pseudopregnant,
lobectomised or virgin mice in a previous experiment.
Our thanks are due to Dr. G. M. Bonser and Dr. D. B. Clayson for encourage-
ment and help in carrying out these experiments and in preparing the manuscript.
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